Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-09
DOI
10.1038/s41598-021-91588-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression
- (2019) Chun-Yu Liu et al. EBioMedicine
- Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
- (2019) Aditya Bardia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
- (2019) Shanu Modi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycoprotein nmb is exposed on the surface of dormant breast cancer cells and induces stem cell-like properties
- (2018) Chen Chen et al. CANCER RESEARCH
- Antibody–drug conjugates in triple negative breast cancer
- (2018) Nancy Tray et al. Future Oncology
- SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment
- (2018) Yu-Hsiang Huang et al. Journal of Clinical Medicine
- Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
- (2018) Steven Horwitz et al. LANCET
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB
- (2017) Yukari Okita et al. Science Signaling
- Knocking down glycoprotein nonmetastatic melanoma protein B suppresses the proliferation, migration, and invasion in bladder cancer cells
- (2017) Yi-xiang Zhang et al. TUMOR BIOLOGY
- Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
- (2017) C A van der Weyden et al. Blood Cancer Journal
- The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB
- (2017) Yukari Okita et al. Science Signaling
- Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
- (2016) Joachim Diessner et al. BMC CANCER
- The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer
- (2016) Aifu Lin et al. NATURE CELL BIOLOGY
- EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer
- (2015) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis
- (2015) G Maric et al. ONCOGENE
- Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system
- (2015) Antonis Koussounadis et al. Scientific Reports
- GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity
- (2014) Chiara Fiorentini et al. EXPERIMENTAL CELL RESEARCH
- Induction of Matrix Metalloproteinase-3 (MMP-3) Expression in the Microglia by Lipopolysaccharide (LPS) via Upregulation of Glycoprotein Nonmetastatic Melanoma B (GPNMB) Expression
- (2014) Fangyuan Shi et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- SGN-LIV1A: A Novel Antibody-Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer
- (2014) D. Sussman et al. MOLECULAR CANCER THERAPEUTICS
- Glycoprotein nonmetastatic B as a prognostic indicator in small cell lung cancer
- (2013) Ying-Na Li et al. APMIS
- Upregulation of Glycoprotein Nonmetastatic B by Colony-Stimulating Factor-1 and Epithelial Cell Adhesion Molecule in Hepatocellular Carcinoma Cells
- (2013) Feng Tian et al. ONCOLOGY RESEARCH
- Novel Genes Associated with Colorectal Cancer Are Revealed by High Resolution Cytogenetic Analysis in a Patient Specific Manner
- (2013) Hisham Eldai et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer
- (2013) Peter Siegel et al. OncoTargets and Therapy
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Identification of valid reference genes for gene expression studies of human stomach cancer by reverse transcription-qPCR
- (2010) Hyun-Wook Rho et al. BMC CANCER
- DC-HIL/Glycoprotein Nmb Promotes Growth of Melanoma in Mice by Inhibiting the Activation of Tumor-Reactive T Cells
- (2010) M. Tomihari et al. CANCER RESEARCH
- Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer
- (2010) A. A. N. Rose et al. CLINICAL CANCER RESEARCH
- ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties
- (2010) April A. N. Rose et al. PLoS One
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
- (2008) S ABDELMAGID et al. EXPERIMENTAL CELL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started